急性喘恶化:管理策略
William Dabbs1, Megan H Bradley2, Shaunta' M Chamberlin2
1The University of Tennessee Graduate School of Medicine, Knoxville, Tennessee; The University of Tennessee Health Science Center, Memphis, Tennessee.
American family physician
|January 16, 2024
概括
喘行动计划指导家庭和办公室管理喘恶化. 早期干预以吸入性皮质类固醇/formoterol,及时治疗以短效β2激动剂和氧气是恢复和预防住院治疗的关键.
科学领域:
- 肺部病理学 肺部病理学
- 过敏和免疫学 过敏和免疫学
- 紧急医疗 紧急医疗
背景情况:
- 喘恶化显著导致发病率和死亡率.
- 喘行动计划对于在家进行症状管理和诊断至关重要.
- 目前的指导方针建议针对不同年龄组使用特定的吸入性皮质类固醇/形式醇或短效β2激动剂策略.
研究的目的:
- 概述当前在各种环境中对喘恶化的管理策略.
- 详细介绍家庭,办公室和急症护理管理喘发作的治疗方法.
- 强调后续护理和患者教育在预防未来恶化的重要性.
主要方法:
- 对喘恶化管理的既定指导方针和临床实践的审查.
- 药理干预措施的描述,包括吸入性皮质类固醇,短效β2激动剂和口服皮质类固醇.
- 评估确定恶化的严重程度和指导治疗决策的标准,包括住院和出院.
主要成果:
- 家庭治疗策略因年龄而异,使用吸入性皮质类固醇/形式醇或短效β2激动剂.
- 办公室和紧急护理涉及短效β2激动剂,氧气和皮质类固醇,考虑短效肌酸抗体和严重病例的硫酸.
- 随着症状改善和肺功能 (预测值的60-80%) 确定出院准备,需要吸入皮质类固醇和随访.
结论:
- 有效地管理喘恶化需要采用多方面的方法,根据严重程度和环境量身定制.
- 及时和适当的治疗,包括药理干预和氧气治疗,对于患者的结果至关重要.
- 加强喘行动计划,优化维持疗法,确保密切跟踪,对于预防复发性恶化至关重要.
相关概念视频
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:30Asthma-IV: Nursing Management
3.1K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.1K
01:20Asthma: Pathogenesis and Management
405
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
405
01:17Drugs Used in Lower Respiratory Disorders: Overview
445
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
445
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
267
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
267
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K